Gene testing for thalassemia

  Thalassemia is one of the most common and harmful single-gene genetic diseases in the world, anemia or pathological state caused by the lack or deficiency of one or more globgenin strains in hemoglobin due to genetic begloper gene defects. Name and classify the type and degree of glober chain deficiency. According to the severity of the disease, divided into heavy, intermediate, light three types, heavy: 3-6 months after birth symptoms, often die in childhood;

    The disease is widely distributed in many parts of the world, black areas of the United States, Southeast Asia, the Indian subcontinent and southern China: Guangdong, Guangxi, Yunnan, Hainan and other places for high-risk areas, the population carrying rate of up to 24%. At least 350 million people worldwide carry the terrestrial poverty gene.

Comprehensive coverage: more comprehensive coverage of the incidence site detection, for each region to carry higher gene mutant type supplement, is currently a hot gene selection more comprehensive CFDA registered products, greatly reducing the risk of missed detection;
High accuracy: detection of known missing types of samples, the results show the corresponding missing type, accuracy is more than 99%;
High specificity: detection of non-poor human genome DNA samples, specifictocoming more than 99%;
Technology reliability: technology platform after many years of clinical and the vast number of hospitals recognized and verified;
Applicability:  The conditions of use are simple and can be carried out in a normal PCR laboratory. 

Causes of thalassemia；
Thalassaemia risk assessment of childcare before pregnancy；
Blocking of children with thalassaemia during pregnancy；
High-risk groups, newborn screening.